Humana Elects David T. Feinberg, M.D. to Board of Directors

Rhea-AI Summary

Humana Inc. (NYSE: HUM) has elected David T. Feinberg, M.D., M.B.A., to its Board of Directors. With over 25 years of experience, Feinberg is currently the CEO of Cerner and previously led Google Health, enhancing healthcare initiatives using technology and innovation. Humana's Chairman, Kurt J. Hilzinger, emphasized Feinberg's expertise in improving clinical care and digital transformation as beneficial for the company's growth and strategy execution. This appointment increases Humana's board to 14 members.

Positive

• David Feinberg's extensive experience in healthcare and technology may bring innovative perspectives to Humana.
• Feinberg's background in digital health initiatives aligns with Humana's strategy to enhance customer experience and reduce costs.

Negative

• Concerns may arise regarding the continuity of leadership and potential experience gaps within Humana's existing board.

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM) announced today that David T. Feinberg, M.D., M.B.A., has been elected as a member of the Company’s Board of Directors. He currently serves as the President, CEO and member of the Board of Directors of Cerner, a supplier of health information technology services, devices and hardware.

Dr. Feinberg is a seasoned industry executive with 25-plus years in senior healthcare leadership roles. Prior to joining Cerner, Dr. Feinberg served as Vice President of Google Health, where he led Google’s worldwide health efforts, bringing together groups from across Google and Alphabet that used artificial intelligence, product expertise and hardware to tackle some of healthcare’s biggest challenges, and was responsible for organizing and innovating Google’s various healthcare initiatives. Before that, Dr. Feinberg served as President and CEO of Geisinger Health and spent more than twenty years at the UCLA, where he served in a number of leadership roles, including President, CEO and Associate Vice Chancellor of UCLA Health Sciences, Vice Chancellor and CEO for the UCLA Hospital System, and CEO of UCLA’s Ronald Reagan Medical Center.

“David is a proven executive with tremendous experience in the healthcare industry, leading organizations focused on technology and digital innovation to improve clinical care,” said Humana Chairman of the Board Kurt J. Hilzinger. “His background, patient-centric mindset, operating experience and expertise in guiding systems transformations will benefit Humana as the Company continues to grow, innovate and execute on its strategy. We are pleased to welcome David to the Humana Board and look forward to benefiting from his perspectives as the Company continues to improve the customer experience, reduce costs and deliver for its shareholders.”

His election brings the number of Humana directors to 14.

About Humana

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of:

• Annual reports to stockholders
• Securities and Exchange Commission filings
• Most recent investor conference presentations
• Quarterly earnings news releases and conference calls
• Calendar of events
• Corporate Governance information

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220301005515/en/

Lisa Stoner

Investor Relations

Humana Inc.

502-580-2652

lstamper@humana.com

or

Mark Taylor

Corporate Communications

Humana Inc.

317-753-0345

mtaylor108@humana.com

Source: Humana Inc.

FAQ

Who is David T. Feinberg and what is his role at Humana?

David T. Feinberg is the newly elected member of Humana's Board of Directors, bringing over 25 years of healthcare leadership experience.

What experience does David T. Feinberg have in the healthcare industry?

Feinberg has served as CEO of Cerner and held leadership roles at Google Health and Geisinger Health.

How does David T. Feinberg's election impact Humana's strategy?

His expertise in technology and digital innovation is expected to enhance Humana’s initiatives to improve clinical care and customer experience.

How many members are now on Humana's Board of Directors?

With Feinberg's election, Humana's Board of Directors now consists of 14 members.